| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACCELERATE DIAGNOSTICS INC | 5,643,540 | 121,280,000 | 21.01% | ||
| 2 | NXSTAGE MED INC COM | 3,291,001 | 72,106,000 | 12.49% | ||
| 3 | QUIDEL CORP COM | 2,796,284 | 59,281,000 | 10.27% | ||
| 4 | PACIFIC BIOSCIENCES CALIF IN | 3,656,431 | 48,009,000 | 8.32% | ||
| 5 | OPKO HEALTH INC | 3,913,800 | 39,334,000 | 6.82% | ||
| 6 | ACORDA THERAPEUTICS | 815,838 | 34,902,000 | 6.05% | ||
| 7 | MAZOR ROBOTICS LTD | 2,816,635 | 28,617,000 | 4.96% | ||
| 8 | TESARO INC | 540,966 | 28,303,000 | 4.90% | ||
| 9 | INTREXON CORP | 932,585 | 28,117,000 | 4.87% | ||
| 10 | ACCURAY INCORPORATED COM | 2,884,305 | 19,469,000 | 3.37% | ||
| 11 | VERMILLION INC | 8,624,225 | 15,524,000 | 2.69% | ||
| 12 | AGENUS INC | 2,865,653 | 13,010,000 | 2.25% | ||
| 13 | AMARIN CORP PLC | 6,645,793 | 12,561,000 | 2.18% | ||
| 14 | WebMD Health Corp | 238,103 | 11,500,000 | 1.99% | ||
| 15 | HANSEN MEDICAL INC | 4,491,820 | 10,466,000 | 1.81% | ||
| 16 | BIOLASE INC | 10,529,525 | 8,856,000 | 1.53% | ||
| 17 | TRANSITION THERAPEUTICS INC | 3,908,461 | 7,504,000 | 1.30% | ||
| 18 | CHIMERIX INC | 736,421 | 6,591,000 | 1.14% | ||
| 19 | CONTRAFECT CORP COM | 1,182,032 | 5,615,000 | 0.97% | ||
| 20 | BIOGEN INC | 7,723 | 2,366,000 | 0.41% | ||
| 21 | METABOLIX INC RESTRICTED | 933,620 | 1,438,000 | 0.25% | ||
| 22 | SECOND SIGHT MED PRODS INC COM | 203,438 | 1,198,000 | 0.21% | ||
| 23 | ZIOPHARM ONCOLOGY INC | 131,551 | 1,093,000 | 0.19% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-16-002847, filed 2016.02.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
